Abstract
The percutaneous route has been recognized as one of the highly potential routes not only for topical drug delivery but also for systemic drug delivery as it provides the advantage of avoidance of the first-pass effect, ease of use and removal (in case of side effects), and better patient compliance. However, the major limitation of this route is the difficult permeation of the drug through the skin. The skin has become an impressive and idealistic platform for the delivery of drugs compared to other routes. However, the stratum corneum or the horny layer, an impermeable barrier of the skin devoid of biological activity, had challenged the development of transdermal products, which deliver drugs directly to the systemic circulation at a controlled rate. Studies have been carried out to find safe and suitable permeation enhancers to promote the percutaneous absorption of a number of drugs. Some of them are niosomes and proniosomes, which ideally possess the property of reversibly reducing the barrier resistance of the horny layer, allowing the drug to reach the living tissues at a greater rate. Niosomes and proniosomes, being colloidal carriers, are still in their infancy and need to be exploited more in the field of dermal and transdermal drug delivery. This chapter explains the state of the art of drug transport through the skin by means of vesicular classic systems: niosomes and proniosomes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abd-Elbary A, El-laithy HM, Tadros MI (2008) Sucrose stearate- based pro-niosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357:189–198
Akhilesh D, Hazel G, Kamath JV (2011) Pro-niosomes – a propitious provesicular drug carrier. Int J Pharm Pharmacol Sci Res 1:98–103
Alam MI, Baboota S, Koili K, Ali J, Ahuja A (2010) Pharmacodynamic evaluation of proniosomal trandermal therapeutic gel containing celecoxib. Sci Asia 36:305–311
Almira I, Welesh AB, Rhodes DG (2001) Maltodextrin based pro-niosomes. AAPS Pharm Sci Tech 3(1):1–8
Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM (2005) Pro-niosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485–490
Arora R, Sharma A (2010) Release studies of Ketoprofen niosome formulation. J Chem Pharm Res 2:79–82
Azeem A, Jain N, Iqbal Z, Ahmad FJ, Aqil M, Talegaonkar S (2008) Feasibility of pro-niosomes based transdermal delivery of frusemide: formulation, optimization and pharmacotechnical evaluation. Pharm Dev Technol 13(2):155–163
Barakat HS, Darwish IA, El-Khordagui LK, Khalafallah NM (2009) Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm 35:631–637
Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug. Eur J Pharm Sci 14:101–114
Benson HA (2006) Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 3:727–737
Bettley FR (1965) The influence of detergents and surfactants on epidermal permeability. Br J Dermatol 77:98–100
Bharti N, Loona S, Khan MMU (2012) Pro-niosomes: a recent advancement in nanotechnology as a drug carrier. Int J Pharm Sci Rev Res 12:67–75
Biju SS, Telegaonar S, Mishra PR, Khar RK (2006) Vesicular system: an overview. Indian J Pharm Sci 68:141–153
Biswal S, Murthy PN, Sahu J, Sahoo P, Amir F (2008) Vesicles of non- ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotechnol 1:1–8
Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13(3):175–187
Carafa M, Santucci E, Lucania G (2002) Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 231(1):21–32
Chandra A, Sharma PK (2008) Pro-niosome based drug delivery system of piroxicam. Afr J Pharm Pharmacol 2(9):184–190
Chien YW (1991) Transdermal systemic drug delivery. Recent development and future prospects. STP Pharma Sci 1:5–23
Chien YW, Keshary PR, Huang YC, Sarpotdar PP (1983) Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems. J Pharm Sci 72:968–970
Choi MJ, Maibach HI (2005) Liposomes and niosomes, as topical drug delivery systems. Skin Pharmacol Physiol 18:209–219
Davis AF, Hadgraft J (1991) Effect of supersaturation on membrane transport: I. Hydrocortisone acetam. Int J Pharm 76:1–8
Dubey A, Prabhu P, Kamath J (2012) Nano structured lipid carriers: a novel topical drug delivery system. Int J PharmTech Res 4(2):705–714
El-Laithy HM, Shoukry O, Mahran LG (2011) Novel sugar esters pro-niosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77(1):43–55
El-Menshawe SF, Hussein AK (2013) Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Dev Technol 18(4):779–786
Fang JY, Hong CT, Chiu WT et al (2001a) Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72
Fang JY, Yu SY, Wu PC, Huang YB (2001b) In-vitro skin permeation of estradiol from various pro-niosome formulations. Int J Pharm 215:91–99
Florence AT (1993) Nonionic surfactant vesicles. Preparation and characterization. In: Gregoriadis G (ed) Liposome technology, vol 2. CRC Press, Boca Raton, pp 157–176
Flynn GL (1990) Physicochemical determinants of skin absorption. In: Gerrity TR, Henry CJ (eds) Principles of route-to-route extrapolation for risk assessment. Elsevier, Amsterdam, pp 93–127
Gross K, Kircik L, Kricorian G (2007) 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33:433–440
Gupta RR, Jain SK, Varshney M (2005) AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B Biointerfaces 41:25–32
Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D (2007) Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6(2):687–693
Gupta M, Vaidya B, Mishra N, Vyas SP (2011) Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol 39:376–384
Guy RH, Hadgraft J (1985) Transdermal drug delivery: the ground rules are emerging. Pharm Int 6:112–116
Guy RH, Hadgraft J (1989) Selection of drug candidates for transdermal drug delivery. In: Hadgraft J, Guy RH (eds) Transdermal drug delivery. Marcel Dekker, New York, pp 59–81
Hagedorn-Leweke U, Lippold BC (1995) Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes. Pharm Res 12:1354–1360
Hamishehkar H, Rahimpour Y, Kouhsoltani M (2013) Niosomes as a propitious carrier for topical drug delivery. Expert Opin Drug Deliv 10(2):261–272
Handjani-Vila RM, Ribier A, Rondot B, Vanlerberghe G (1979) Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci 1:303–314
Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T (2005) Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 288(2):227–233
Hofland HEJ, Bouwstra JA, Ponec M, Bodde HE, Spies F, Verhoef JC, Junginger HE (1991) Interactions of non-ionic surfactant vesicles with cultured keratinocytes and human skin in vitro. A survey of toxicological aspects and ultrastructural changes in stratum corneum. J Control Release 16:155–167
Hofland HEJ, van der Geest R, Bodde HE, Junginger HE, Bouwstra JA (1994) Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 11:659–664
Hu C, Rhodes DG (1999) Pro-niosomes: a novel drug carrier preparation. Int J Pharm 185:23–35
Inayat BP, Mallikarjuna SC (2009) Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8(2):173–179
Indhu PK, Garg A, Anil KS, Aggarwal D (2004) Vesicular system in ocular drug delivery. Indian J Pharm Sci 269:1–14
Jain S, Singh P, Mishra V, Vyas SP (2005) Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis B. Immunol Lett 101:41–49
Jayaraman CS, Ramachandran C, Weiner N (1996) Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J Pharm Sci 85(10):1082–1084
Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D (2012) Physicochemical properties and skin permeation of span 60/tween 60 niosomes of ellagic acid. Int J Pharm 423(2):303–311
Kakkar R, Rao R, Dahiya NK, Nanda S (2011) Formulation and characterization of valsartan pro-niosomes. Maejo Int J Sci Technol 5(01):146–158
Kushla GP, Zatz JL, Millis OH, Berger RS (1993) Noninvasive assessment of anesthetic activity of Lidocaine formulations. J Pharm Sci 82:118–1122
Lawrence MJ, Chauhan S, Lawrence SM, Barlow DJ (1996) The formation, characterization and stability of non-ionic surfactant vesicles. STP Pharma Sci 1:49–60
Le VH, Lippold BC (1995) Influence of physicochemical properties of homologous esters of nicotinic acid on skin permeability and maximum flux. Int J Pharm 124:285–292
Lohumi A, Rawat S, Sarkar S, Sipai A, Yadav MV (2012) A novel drug delivery system: niosomes review. J Drug Delive Ther 2(5):129–135
Maheshwari C, Pandey RS, Chaurasiya A, Kumar A, Selvam DT, Prasad GB, Dixit VK (2011) Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B. Int Immunopharmacol 11:1516–1522
Manconi M, Sinico C, Valenti D, Lai F, Fadda AM (2006) Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 311:11–19
Manosroi A, Jantrawut P, Akazawa H, Akihisa T, Manosroi W, Manosroi J (2011) Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls. Pharm Biol 49:553–562
Manosroi A, Ruksiriwanich W, Abe M, Manosroi W, Manosroi J (2012) Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction. Eur J Pharm Biopharm 81(2):303–313
Mokhtar M, Sammour OA, Hammad MA, Megrab NA (2008) Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from pro-niosomes. Int J Pharm 361(1–2):104–111
Mura S, Pirot F, Manconi M, Falson F, Fadda AM (2007) Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 15:101–108
Muzzalupo R, Tavano L, Nicoletta FP, Trombino S, Cassano R, Picci N (2010) Liquid crystalline Pluronic 105 pharmacogels as drug delivery systems: preparation, characterization and in vitro transdermal release. J Drug Target 8:404–411
Nasr M, Mansour S, Mortada ND, Elshamy AA (2008) Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25(7):499–512
Pandey N (2011) Pro-niosomes and ethosomes: new prospect in transdermal and dermal drug delivery system Int. J Pharm Sci Res 2(8):1988–1996
Paolino D, Muzzalupo R, Ricciardi A, Celia C, Picci N, Fresta M (2007) In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Biomed Microdevices 9:421–433
Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M (2008) Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 353(1):233–242
Pfister WR, Dean S, Hsieh ST (1990) Permeation enhancers compatible with transdermal delivery systems. Part I: selection and formulation considerations. Pharm Technol X:132–140
Rubio L, Alonso C, López O, Rodríguez G, Coderch L, Notario J, de la Maza A, Parra JL (2011) Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid. Int J Dermatol 50(7):881–889
Sahin NO (2007) Niosomes as nanocarrier systems. In: Mozafari MR (ed) Nanomaterials and nanosystems for biomedical applications. Springer, Dordrecht, pp 67–81
Sankhyan A, Pawar P (2012) Recent trends in niosome as vesicular drug delivery system. J Appl Pharm Sci 02(06):20–32
Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 30(1):1–15
Shahiwala A, Misra A (2002) Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 5:220–225
Shamsheer Ahmad S, Sabareesh M, Patan Rafi Khan, Sai Krishna P, Sudheer B (2011) Formulation and evaluation of lisinopril dihydrate transdermal proniosomal gels. J Appl Pharm Sci 01(08):181–185
Singh BN, Singh RB, Singh J (2005) Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 298:98–107
Sinha VR, Kaur MP (2000) Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26(11):1131–1140
Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM (2005) Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 103:123–136
Solankia AB, Parikh JR, Parikh RH, Patel MR (2010) Evaluation of different compositions of niosomes to optimize Aceclofenac transdermal delivery. Asian J Pharm Sci 5:87–95
Srikanth K, Nappinnai M, Gupta VRM, Suribabu J (2010) Niosomes: a prominent tool for transdermal drug delivery. Res J Pharm Bio Chem Sci 1:308–316
Sudhamani T, Priyadarisini N, Radhakrishna M (2010) Pro-niosomes – a promising drug carriers. Int J PharmTech Res 2:1446–1454
Tavano L, Alfano P, Muzzalupo R, Cindio B (2011) Niosomes vs microemulsions: new carriers for topical delivery of capsaicin. Colloids Surf B Biointerfaces 87:333–339
Thakur R, Anwer MK, Shams MS, Ali A, Khar RK, Shakeel F, Taha EI (2009) Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. J Drug Target 17(6):442–449
Tojo K, Keshary PR, Chien YW (1986) Drug permeation through skin from matrix-type drug delivery systems. Chem Eng J 32:57–64
Uchegbu IF, Vyas SP (1998) Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
Udupa N (2004) Niosomes as drug carriers. In: Jain NK (ed) Controlled and novel drug delivery. CBS Publishers & Distributors, New Delhi, pp 292–303
Vanhal D, Vanrensen A, Devinger T, Junginger H, Bouwstra J (1996) Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro. STP Pharma Sci 6:72–78
Varshosaz J, Pardakhty A, Baharanchi SM (2005) Sorbitan monopalmitate-based pro-niosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv 12(2):75–82
Venuganti VV, Perumal OP (2009) Nanosystems for dermal and transdermal drug delivery. In: Pathak Y, Thassu D (eds) Drug delivery nanoparticles formulation and characterization. Informa Healthcare USA, Inc, New York, pp 126–155
Verma S, Singh SK, Navneet S, Mathur P, Valecha V (2010) Nanoparticle vesicular systems: a versatile tool for drug delivery. J Chem Pharm Res 2:496–509
Vora B, Khopade AJ, Jain NK (1998) Pro-niosome based transdermal delivery of levonogesterol for effective contraception. J Control Release 54:149–165
Vyas SP, Khar RK (2002) Controlled drug delivery system: concept and advances. CBS Publishers and Distributors, New Delhi
Vyas SP, Khar RK (2011) Targeted and controlled drug delivery novel carrier systems. CBS Publishers and Distributors, New Delhi, pp 249–279
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev. 56:603–618
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Muzzalupo, R. (2016). Niosomes and Proniosomes for Enhanced Skin Delivery. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47862-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-47862-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47861-5
Online ISBN: 978-3-662-47862-2
eBook Packages: MedicineMedicine (R0)